SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis
14 references·0 citing·50 second hop
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis (2019)Changes in Dosing and Dose Timing of D-Cy…Cognitive behavioral therapy for anxiety and related disorders: A meta‐analysis of randomized placebo‐controlled trials (2018)Cognitive behavioral therapy …The intriguing evolution of effect sizes in biomedical research over time: smaller but more often statistically significant (2017)The intriguing evolution of e…D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders (2017)D-Cycloserine Augmentation of…RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER (2016)RANDOMIZED TRIAL OF D-CYCLOSE…Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d -Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder (2016)Efficacy of Augmentation of C…Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions (2015)Enhancement of Psychosocial T…Does D-Cycloserine Enhance Exposure Therapy for Anxiety Disorders in Humans? A Meta-Analysis (2014)Does D-Cycloserine Enhance Ex…d-Cycloserine Augmentation of Cognitive Behavioral Therapy for Anxiety Disorders: an Update (2014)d-Cycloserine Augmentation of…d -Cycloserine Augmentation of Behavioral Therapy for the Treatment of Anxiety Disorders (2012)d -Cycloserine Augmentation o…Cognitive enhancers for anxiety disorders (2010)Cognitive enhancers for anxie…The fading of reported effectiveness. A meta-analysis of randomised controlled trials (2006)The fading of reported effect…Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder (2006)Augmentation of Exposure Ther…Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time (2004)Effect sizes in cumulative me…Cognitive Enhancers as Adjuncts to Psychotherapy (2004)Cognitive Enhancers as Adjunc…Empirical Evidence of Bias (1995)Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)Bias in meta-analysis detected by a simple, graphical test (1997)Regression to the mean in substance use disorder treatment research (2007)CORRUPTION'S DIRECT EFFECTS ON PER‐CAPITA INCOME GROWTH: A META‐ANALYSIS (2013)Replication Research and Special Education (2016)A Randomized, Double-Blind Evaluation of d -Cycloserine or Alprazolam Combined With Virtual Reality Exposure Therapy for Posttraumatic Stress Disorder in Iraq and Afghanistan War Veterans (2014)Diagnosis and Management of Anxiety Disorders (2018)Meta-analysis in clinical trials (1986)Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction (1992)Direction and impact of language bias in meta-analyses of controlled trials: empirical study (2002)Cultural competence and evidence-based practice in mental health: Epistemic communities and the politics of pluralism (2012)Efficacy of Pharmacotherapy and Psychotherapy for Adult Psychiatric Disorders (2014)The Robustness of the Corporate Social and Financial Performance Relation: A Second‐Order Meta‐Analysis (2018)Quantifying heterogeneity in a meta‐analysis (2002)Cochrane Handbook for Systematic Reviews of Interventions (2008)Diagnostic and Statistical Manual of Mental Disorders (2013)Anorexia nervosa as a motivated behavior: Relevance of anxiety, stress, fear and learning (2015)Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders (2015)Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy (2016)The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses (2012)Psychopharmacological Strategies in the Management of Posttraumatic Stress Disorder (PTSD): What Have We Learned? (2015)PTSD as a memory disorder (2015)Core Mechanisms of Cognitive Behavioral Therapy for Anxiety and Depression (2017)ECDEU Assessment Manual for Psychopharmacology (1976)Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Structured Clinical Interview for DSM-IV Axis I Disorders (1997)Fear Extinction in Traumatized Civilians with Posttraumatic Stress Disorder: Relation to Symptom Severity (2010)How the Neurocircuitry and Genetics of Fear Inhibition May Inform Our Understanding of PTSD (2010)Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options (2020)An Inventory for Measuring Depression (1961)Manual for the state-trait anxiety inventory (form Y) : "self-evaluation questionnaire" (1970)The Structured Clinical Interview for DSM-III-R (SCID) (1992)Response Variation following Trauma: A Translational Neuroscience Approach to Understanding PTSD (2007)Understanding how and why psychotherapy leads to change (2008)Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014)Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial Reliability and Validity Data (1997)Wechsler Abbreviated Scale of Intelligence (2014)New Directions in the Cognitive-Behavioral Treatment of OCD: Theory, Research, and Practice (2017)Evidence Base Update of Psychosocial Treatments for Pediatric Obsessive-Compulsive Disorder: Evaluating, Improving, and Transporting What Works (2018)Obsessive-compulsive disorder in children and adolescents: epidemiology, diagnosis and management (2020)Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. (2007)The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD) (2018)Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019)Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder (2021)Measuring inconsistency in meta-analyses (2003)Climate anxiety: Psychological responses to climate change (2020)Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts (2020)The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses (2022)
this work references cited by second hop

References

  • 2004Cognitive Enhancers as Adjuncts to Psychotherapy1,063 cited
  • 2018Cognitive behavioral therapy for anxiety and related disorders: A meta‐analysis of randomized placebo‐controlled trials846 cited
  • 2006Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder560 cited
  • 2017D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders288 cited
  • 2004Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time177 cited
  • 2014Does D-Cycloserine Enhance Exposure Therapy for Anxiety Disorders in Humans? A Meta-Analysis109 cited
  • 2016Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d -Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder107 cited
  • 2006The fading of reported effectiveness. A meta-analysis of randomised controlled trials88 cited
  • 2014d-Cycloserine Augmentation of Cognitive Behavioral Therapy for Anxiety Disorders: an Update76 cited
  • 2015Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions70 cited
  • 2012d -Cycloserine Augmentation of Behavioral Therapy for the Treatment of Anxiety Disorders69 cited
  • 2016RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER69 cited
  • 2010Cognitive enhancers for anxiety disorders68 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2017The intriguing evolution of effect sizes in biomedical research over time: smaller but more often statistically significant37 cited
  • Cited by

    No citing works inside the corpus for this window.